Trial · NCT05080049
Erythropoietin to Improve Critical Care Patient Outcomes
NCT05080049, Phase 3, Unknown, University Hospital, Angers
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Erythropoietin to Improve Critical Care Patient Outcomes. Trials, record NCT05080049. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05080049
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Erythropoietin to Improve Critical Care Patient Outcomes
- NCT number
- NCT05080049
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 42 participants, actual
- Lead sponsor
- University Hospital, Angers
- Conditions
- Anemia, Intensive Care
- Interventions
- Erythropoietin, Placebo
- First posted
- 2021-10-15
- Last updated
- 2022-10-10
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Recruitment rate | 90 days | ≥50% of eligible patients will need to be enrolled, but the trial will not be feasible if the inclusion rate is ≤ 25% or less |
| Primary | Adherence to allocation groups | 90 days | A high level of matching of randomization and group allocation should be achieved, with at least 85% of included patients receiving protocol-allocated treatment, but if ≤ 65% patients receive protocol-allocated treatment, the trial is not feasible |
| Primary | Completion of follow-up of included patients | 90 days | ≥ 85% of patients should be followed through to the end of follow-up, but if \<65% patients are followed through to the last visit, the protocol will not be feasible |
| Secondary | The proportion of patients lost to follow-up at each visit | 7, 14, 21, 28 and 90 days | The proportion of patients lost to follow-up at each visit |
| Secondary | The rate of missing data for mortality outcome | 90 days | The rate of missing data for mortality outcome |
| Secondary | The rate of compliance with the therapeutic protocol at each visit for inpatients | 7, 14, 21, and 28 days | The rate of compliance with the therapeutic protocol at each visit for inpatients |
| Secondary | Mean serum hemoglobin value | 28 days | Mean serum hemoglobin value |
| Secondary | ICU mortality | up to 90 days | ICU mortality |
| Secondary | Hospital mortality | up to 90 days | Hospital mortality |
| Secondary | ICU length of stay | up to 90 days | ICU length of stay |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05080049
GET https://conductscience.org/api/trials/v1/NCT05080049/registered